A Quantitative Affinity-Profiling System That Reveals Distinct CD4/CCR5 Usage Patterns among Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus Strains

被引:80
|
作者
Johnston, Samantha H. [1 ,2 ]
Lobritz, Michael A. [3 ]
Nguyen, Sandra [1 ]
Lassen, Kara [4 ]
Delair, Shirley [1 ,2 ]
Posta, Filippo [5 ,6 ]
Bryson, Yvonne J. [2 ]
Arts, Eric J. [3 ]
Chou, Tom [5 ,6 ]
Lee, Benhur [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Infect Dis, Los Angeles, CA 90095 USA
[3] Case Western Reserve Univ, Sch Med, Div Infect Dis, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA
[5] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90095 USA
[6] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90095 USA
基金
美国国家科学基金会;
关键词
MONOCYTE-DERIVED MACROPHAGES; DISEASE PROGRESSION; CORECEPTOR SPECIFICITY; EXPERIENCED PATIENTS; HIV-1; INFECTION; ENVELOPE GENE; TROPIC HIV-1; CCR5; RECEPTOR; VARIANTS;
D O I
10.1128/JVI.01242-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The affinity of human immunodeficiency virus (HIV) envelope for CD4 and CCR5 appears to be associated with aspects of R5 virus (virus using the CCR5 coreceptor) pathogenicity. However, entry efficiency results from complex interactions between the viral envelope glycoprotein and both CD4 and CCR5, which limits attempts to correlate viral pathogenicity with surrogate measures of envelope CD4 and CCR5 affinities. Here, we present a system that provides a quantitative and comprehensive characterization of viral entry efficiency as a direct interdependent function of both CD4 and CCR5 levels. This receptor affinity profiling system also revealed heretofore unappreciated complexities underlying CD4/CCR5 usage. We first developed a dually inducible cell line in which CD4 and CCR5 could be simultaneously and independently regulated within a physiologic range of surface expression. Infection by multiple HIV type 1 (HIV-1) and simian immunodeficiency virus isolates could be examined simultaneously for up to 48 different combinations of CD4/CCR5 expression levels, resulting in a distinct usage pattern for each virus. Thus, each virus generated a unique three-dimensional surface plot in which viral infectivity varied as a function of both CD4 and CCR5 expression. From this functional form, we obtained a sensitivity vector along with corresponding metrics that quantified an isolate's overall efficiency of CD4/CCR5 usage. When applied to viral isolates with well-characterized sensitivities to entry/fusion inhibitors, the vector metrics were able to encapsulate their known biological phenotypes. The application of the vector metrics also indicated that envelopes derived from elite suppressors had overall-reduced entry efficiencies compared to those of envelopes derived from chronically infected viremic progressors. Our affinity-profiling system may help to refine studies of R5 virus tropism and pathogenesis.
引用
收藏
页码:11016 / 11026
页数:11
相关论文
共 50 条
  • [21] CD4+ T cell surface CCR5 density and virus load in persons infected with human immunodeficiency virus type 1 -: Reply
    Reynes, J
    Portales, P
    Clot, J
    Corbeau, P
    JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04): : 1285 - 1286
  • [22] Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor
    Platt, EJ
    Madani, N
    Kozak, SL
    Kabat, D
    JOURNAL OF VIROLOGY, 1997, 71 (02) : 883 - 890
  • [23] Activation of β-chemokines and CCR5 in persons infected with human immunodeficiency virus type 1 and tuberculosis
    Mayanja-Kizza, H
    Wajja, A
    Wu, MD
    Peters, P
    Nalugwa, G
    Mubiru, F
    Aung, H
    Vanham, G
    Hirsch, C
    Whalen, C
    Ellner, J
    Toossi, Z
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (12): : 1801 - 1804
  • [24] CCR5 genotype and human immunodeficiency virus type 1 infection in perinatally exposed infants
    Villalba, N
    Pérez-Olmeda, M
    de José, M
    Hernández, M
    Sirera, R
    Español, T
    González-Molina, A
    Soriano, V
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (05) : 389 - 391
  • [25] CCR5 Genotype and Human Immunodeficiency Virus Type 1 Infection in Perinatally Exposed Infants
    N. Villalba
    M. Pérez-Olmeda
    M. de José
    M. Hernández
    R. Sirera
    T. Español
    A. González-Molina
    V. Soriano
    European Journal of Clinical Microbiology and Infectious Diseases, 1999, 18 : 389 - 391
  • [26] Maraviroc, a CCR5 Coreceptor Antagonist That Blocks Entry of Human Immunodeficiency Virus Type 1
    Hunt, Joshua S.
    Romanelli, Frank
    PHARMACOTHERAPY, 2009, 29 (03): : 295 - 304
  • [27] Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1
    Kuhmann, SE
    Platt, EJ
    Kozak, SL
    Kabat, D
    JOURNAL OF VIROLOGY, 2000, 74 (15) : 7005 - 7015
  • [28] Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1
    Coberley, CR
    Kohler, JJ
    Brown, JN
    Oshier, JT
    Baker, HV
    Popp, MP
    Sleasman, JW
    Goodenow, MM
    JOURNAL OF VIROLOGY, 2004, 78 (21) : 11477 - 11486
  • [29] Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4 and/or CCR5
    Hug, P
    Lin, HMJ
    Korte, T
    Xiao, X
    Dimitrov, D
    Wang, JM
    Puri, A
    Blumenthal, R
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 300A - 300A
  • [30] Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5
    Hug, P
    Lin, HMJ
    Korte, T
    Xiao, XD
    Dimitrov, DS
    Wang, JM
    Puri, A
    Blumenthal, R
    JOURNAL OF VIROLOGY, 2000, 74 (14) : 6377 - 6385